CHAMPION BRIEF · INTERNAL
The room became a decision brief.
Drafted for Dr. Lena Park to forward to VP / CISO / Legal. Trovii turns live trial signal into the internal narrative a champion needs to move adoption forward.
LIVE ROUND-TRIP STATUS
Latest live capture is now in this brief: adoption-blocker · Jenn demo proof: customer champion says Legal will not approve until Google provides a one-page BAA-safe architecture pattern.
GOOGLE BEAM · TRIAL INTELLIGENCE
AXIOM HEALTH
The room became a decision.
WHO’S IN THE ROOM · ALIGNMENT
13
LIVESIGNALS CAPTURED
3
LIVEUSE CASES CONFIRMED
4
LIVEOPEN RISKS
2/1
LIVEADVOCATES / SKEPTICS
54%
MODELEDRENEWAL CONFIDENCEⓘ
advocates×2 + use-cases ÷ that + skeptics×2 + risks · modeled
RENEWAL-CONFIDENCE READ
2 advocates (incl. champion Park), 3 use cases confirmed, 4 open risks and 1 skeptic to win over · 1 adjacent expansion surfaced. The brief below is built from these signals — forwardable to VP / CISO / Legal.
HUMAN VALUE
The team stays with the customer instead of becoming note-takers.
STRATEGIC VALUE
GTM can show why the trial is blocked, not just that it happened.
PRODUCT VALUE
Customer language becomes docs, roadmap, and enablement signal.
01 · WHAT WE'RE TRYING TO PROVE
Test Gemini for tier-2 customer support across our member portal. Goal: 35% deflection of tier-2 tickets in 60 days without compromising compliance review.
02 · USE CASES CONFIRMED IN TRIAL
- · Member-eligibility questions: 'is this procedure covered?' — currently 18% of tier-2 volume.(Dr. Lena Park)
- · Prior-auth status lookups — 22% of tier-2 volume, currently bounced to a human in 90s.(Priya Shah)
- · Spanish-language support queries — 14% of member base, currently outsourced. Could be a deflection-on-deflection win.(Priya Shah)
03 · RISKS ACKNOWLEDGED (FOR LEGAL + CISO)
- · We can't put member-specific medical context into the model without a BAA review.(high · Marcus Ito (CISO))
- · Legal needs a logged audit trail for every model response that touches PHI.(high · Tom Chen (Legal))
- · No standard pattern for HIPAA-safe context injection in the Gemini SDK. Champion needs a docs page they can show legal.(high · Dr. Lena Park)
- · Jenn demo proof: customer champion says Legal will not approve until Google provides a one-page BAA-safe architecture pattern.(high · Live capture · tap)
04 · STAKEHOLDER ALIGNMENT
- Dr. Lena Park · VP Customer Ops · championadvocate
- Marcus Ito · CISOskeptic
- Priya Shah · Customer Support Directoradvocate
- Tom Chen · Legal · HIPAA reviewerneutral
- Sasha Klein · Member Experience Leadneutral
05 · SUCCESS CRITERIA · STATUS
- · ≥35% deflection of tier-2 tickets in 60 days
- · Zero HIPAA incidents
- · Member CSAT not lower than baseline
- · Champion can demo end-to-end without engineer present by day 30
06 · WHAT WE NEED THIS WEEK
- 1. Send champion the BAA-compliant reference architecture by Friday
- 2. Pull DevRel into a 30-min session with Marcus (CISO) to walk the security model
- 3. Unblock: No standard pattern for HIPAA-safe context injection in the Gemini SDK. Champion needs a docs page they can show legal
07 · ADJACENT OPPORTUNITIES
- · If tier-2 deflection works, champion is interested in Gemini for clinical-trial recruitment screening — separate $1.2M opportunity.
08 · DRAFTED FOLLOW-UP · CHAMPION-READY
auto-synthesized · templateOne-click email for Dr. Lena Park to forward to VP / CISO / Legal. Built from the 13 captured signals above. Editable before send.
Hi all, Quick update on the Axiom Health → Google trial. I want to get ahead of the questions Marcus will ask, so I'm getting this in front of you before our next sync. The thesis we're testing: Test Gemini for tier-2 customer support across our member portal. Goal: 35% deflection of tier-2 tickets in 60 days without compromising compliance review. What's clearly working so far: Member-eligibility questions: 'is this procedure covered?' — currently 18% of tier-2 volume, Prior-auth status lookups — 22% of tier-2 volume, currently bounced to a human in 90s, and Spanish-language support queries — 14% of member base, currently outsourced. Could be a deflection-on-deflection win. Together those represent the largest slice of the workload we've been trying to move. The risks we've surfaced — and are actively working: we can't put member-specific medical context into the model without a baa review, legal needs a logged audit trail for every model response that touches phi, and no standard pattern for hipaa-safe context injection in the gemini sdk. champion needs a docs page they can show legal. None of these are dealbreakers; each has an owner and a path forward. The decisions I need this week: Send champion the BAA-compliant reference architecture by Friday and Pull DevRel into a 30-min session with Marcus (CISO) to walk the security model. If we land this pilot, the adjacent opportunity is real: if tier-2 deflection works, champion is interested in gemini for clinical-trial recruitment screening — separate $1.2m opportunity. Worth flagging now so it doesn't surprise you in Q3 planning. Happy to walk any of this through live. The signals behind every line above are captured in the Trovii workspace if you want to drill in. — Park